Pharmaceutical

Grünenthal gains Valinor Pharma and constipation drug Movantik

Grünenthal has announced the acquisition of Valinor Pharma and its opioid-induced constipation (OIC) therapy Movantik for $250m.

Jul 24, 2024 - 04:00
Grünenthal gains Valinor Pharma and constipation drug Movantik
Grünenthal has announced the acquisition of Valinor Pharma and its opioid-induced constipation (OIC) therapy Movantik for $250m.
Read the original article

Tags:

Previous Article

Johnson & Johnson submits sNDA for SPRAVATO to treat depression

Next Article

UNAIDS boss calls on Gilead to provide ‘miracle’ drug to developing countries

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Small study adds to growing hope CAR-T cell therapy could revolutionize autoimmune disease treatment

Small study adds to growing hope CAR-T cell therapy cou...

Feb 21, 2024

Epic and Microsoft’s AI collaboration, Amazon and 3M, & Abbott’s CGM momentum

Epic and Microsoft’s AI collaboration, Amazon and 3M, &...

Apr 21, 2023

Signal: PureHealth UK expansion shows continued focus on healthcare in UAE

Signal: PureHealth UK expansion shows continued focus o...

Aug 30, 2023